A Phase 2 Clinical Trial Evaluating the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Patients with Duchenne Muscular Dystrophy (DMD)Jerry Mendell,Perry Shieh,Zarife Sahenk,Kelly Lehman,Linda Lowes,Natalie Reash,Megan Iammarino,Lindsay Alfano, Brenna Sabo,Jeremy Woods,Christy Skura,Howard Mao,Loretta Staudt,Rachael Potter,Danielle Griffin,Sarah Lewis,Shufang Wang,Tejdip Singh,Louise Rodino-KlapacNEUROLOGY（2023）引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
